George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 402,500 shares at $44.85 ($18.6M) on 2021-06-04, disclosed to the SEC on 2021-06-08.
Open-market sale of $18.6M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.69 | 20,000 | $894K | 4.8% |
| 2 | $44.81 | 20,000 | $896K | 4.8% |
| 3 | $44.85 | 20,000 | $897K | 4.8% |
| 4 | $45.89 | 15,147 | $695K | 3.7% |
| 5 | $45.89 | 15,147 | $695K | 3.7% |
| 6 | $45.97 | 19,100 |
| $878K |
| 4.7% |
| 7 | $46.10 | 33,381 | $1.5M | 8.3% |
| 8 | $46.10 | 33,381 | $1.5M | 8.3% |
| 9 | $46.54 | 4,853 | $226K | 1.2% |
| 10 | $46.54 | 4,853 | $226K | 1.2% |
| 11 | $46.74 | 36,619 | $1.7M | 9.2% |
| 12 | $46.74 | 36,619 | $1.7M | 9.2% |
| 13 | $46.77 | 13,400 | $627K | 3.4% |
| 14 | $46.47 | 10,000 | $465K | 2.5% |
| 15 | $46.48 | 20,000 | $930K | 5.0% |
| 16 | $46.48 | 20,000 | $930K | 5.0% |
| 17 | $46.48 | 40,000 | $1.9M | 10.0% |
| 18 | $46.48 | 40,000 | $1.9M | 10.0% |
| Total | $46.15 avg | 402,500 | $18.6M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |